89
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients

, , , , , ORCID Icon & show all
Pages 2269-2277 | Published online: 17 Jun 2021

References

  • Hoehl S, Rabenau H, Berger A, et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med. 2020;382(13):1278–1280. doi:10.1056/NEJMc200189932069388
  • Chinazzi M, Davis JT, Ajelli M, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400. doi:10.1126/science.aba975732144116
  • Ceylan Z. Estimation of COVID-19 prevalence in Italy, Spain, and France. Sci Total Environ. 2020;729:138817. doi:10.1016/j.scitotenv.2020.13881732360907
  • Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.539432250385
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
  • Bialek S, Bowen V, Chow N; Team CC-R. Geographic differences in COVID-19 cases, deaths, and incidence - United States, February 12-April 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):465–471. doi:10.15585/mmwr.mm6915e432298250
  • Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. Polymerase chain reaction assays reverted to positive in 25 discharged patients with COVID-19. Clin Infect Dis. 2020;71(16):2230–2232. doi:10.1093/cid/ciaa39832266381
  • Gupta S, Raghuwanshi GS, Chanda A. Effect of weather on COVID-19 spread in the US: a prediction model for India in 2020. Sci Total Environ. 2020;728:138860. doi:10.1016/j.scitotenv.2020.13886032334160
  • Jia JS, Lu X, Yuan Y, Xu G, Jia J, Christakis NA. Population flow drives spatio-temporal distribution of COVID-19 in China. Nature. 2020;582(7812):389–394. doi:10.1038/s41586-020-2284-y32349120
  • Weiming T, Huipeng L, Gifty M, et al. The changing patterns of Coronavirus Disease 2019 (COVID-19) in China: a tempogeographic analysis of the severe acute respiratory syndrome coronavirus 2 epidemic. Clin Infect Dis. 2020;71(15):818–824. doi:10.1093/cid/ciaa42332296826
  • Pan A, Liu L, Wang C, et al. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA. 2020;323(19):1915–1923. doi:10.1001/jama.2020.613032275295
  • Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036–1045. doi:10.1016/j.cell.2020.04.02632416070
  • Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564–1581. doi:10.1111/all.1436432396996
  • Schett G, Sticherling M, Neurath MF. COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat Rev Immunol. 2020;20(5):271–272. doi:10.1038/s41577-020-0312-732296135
  • Butowt R, Bilinska K, Von Bartheld CS. Chemosensory dysfunction in COVID-19: integration of genetic and epidemiological data points to D614G spike protein variant as a contributing factor. ACS Chem Neurosci. 2020;11(20):3180–3184. doi:10.1021/acschemneuro.0c0059632997488
  • Li Q, Wu J, Nie J, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020;182(5):1284–1294 e1289. doi:10.1016/j.cell.2020.07.01232730807
  • Volz E, Hill V, McCrone JT, et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184(1):64–75 e11.33275900
  • Nguyen HT, Zhang S, Wang Q, et al. Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects. J Virol. 2020;11:JVI.02304–20.
  • von Bartheld CS, Hagen MM, Butowt R. Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neurosci. 2020;11(19):2944–2961. doi:10.1021/acschemneuro.0c0046032870641
  • Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827 e819. doi:10.1016/j.cell.2020.06.04332697968